Differences
This shows you the differences between two versions of the page.
obsessive-compulsive_disorder [2025/05/13 06:15] – created administrador | obsessive-compulsive_disorder [2025/07/17 14:01] (current) – [Treatment] administrador | ||
---|---|---|---|
Line 1: | Line 1: | ||
+ | ====== Obsessive-compulsive disorder ====== | ||
+ | OCD is a mental health condition characterized by recurrent, intrusive thoughts (obsessions) and repetitive behaviors or mental acts (compulsions) aimed at reducing distress. | ||
+ | |||
+ | A debilitating psychiatric disorder characterized by anxiety-provoking intrusive thoughts (obsessions) that lead to stereotyped motor, cognitive acts, or rituals that are performed (compulsions) to relieve the associated anxiety | ||
+ | ((Shah DB, Pesiridou A, Baltuch GH, et al. Functional neurosurgery in the treatment of severe obsessive compulsive disorder and major depression: overview of disease circuits and therapeutic targeting for the clinician. Psychiatry (Edgmont). 2008; 5: | ||
+ | |||
+ | It affects up to 2% of the population and is the 10th leading cause of disability worldwide | ||
+ | ((Narrow WE, Rae DS, Robins LN, et al. Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' | ||
+ | ((Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997; 349: | ||
+ | |||
+ | 12–20% of cases remain refractory to standard behavioral psychotherapy and medical treatment with serotonin reuptake inhibitors (SSRI) or atypical antipsychotics | ||
+ | ((Eisen JL, Goodman WK, Keller MB, et al. Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study. J Clin Psychiatry. 1999; 60: | ||
+ | |||
+ | DBS targets explored for OCD include the anterior limb of the internal capsule (ALIC), nucleus accumbens (NAc), ventral capsule / ventral striatum (VC/VS), [[subthalamic nucleus]] (STN), and inferior thalamic peduncle (ITP) | ||
+ | ((Greenberg BD, Gabriels LA, Malone DA, Jr, et al. Deep brain stimulation of the ventral internal capsule/ | ||
+ | ((Sturm V, Lenartz D, Koulousakis A, et al. The nucleus accumbens: a target for deep brain stimulation in obsessive-compulsive- and anxiety-disorders. J Chem Neuroanat. 2003; 26: | ||
+ | |||
+ | The FDA recently granted a humanitarian device exemption approving the use of VC/VS DBS for medically intractable OCD. | ||
+ | ---- | ||
+ | |||
+ | |||
+ | [[Obsessive]]-compulsive disorder (OCD) is an [[anxiety]] disorder characterized by intrusive thoughts that produce uneasiness, apprehension, | ||
+ | |||
+ | ====Symptoms==== | ||
+ | Include excessive washing or cleaning, repeated checking, extreme hoarding, preoccupation with sexual, violent or religious thoughts, relationship-related obsessions, aversion to particular numbers and nervous rituals such as opening and closing a door a certain number of times before entering or leaving a room. These symptoms are time-consuming, | ||
+ | |||
+ | A number of psychological and biological factors may be involved in causing obsessive-compulsive disorder. | ||
+ | |||
+ | Other disorders with similar symptoms include obsessive-compulsive personality disorder (OCPD), an autism spectrum disorder, or disorders where perseveration (hyperfocus) is a feature in ADHD, PTSD, bodily disorders, or just a habit problem. | ||
+ | |||
+ | ====Scales==== | ||
+ | |||
+ | Standardized rating scales such as [[Yale Brown Obsessive Compulsive Scale]] can be used to assess the severity of symptoms. | ||
+ | |||
+ | ===== Treatment ===== | ||
+ | |||
+ | see [[Obsessive-compulsive disorder treatment]]. | ||
+ | |||
+ | ===== Bibliometric Analysis ===== | ||
+ | |||
+ | ===== Mapping research trends in obsessive-compulsive disorder before and after the COVID-19 pandemic: a bibliometric analysis focusing on its molecular mechanisms ===== | ||
+ | |||
+ | **Study Type:** Bibliometric analysis | ||
+ | **First Author:** Yuito Inoue et al. | ||
+ | **Author Affiliations: | ||
+ | **Journal: | ||
+ | **Purpose: | ||
+ | **Conclusions: | ||
+ | |||
+ | ==== Critical Review ==== | ||
+ | |||
+ | While the topic is timely and potentially valuable, the analysis remains superficial. The authors correctly identify a shift in research focus post-COVID-19 but fail to deliver actionable insights for translational science or clinical practice. The reliance on keyword frequency without rigorous quantitative weighting or meta-level correlation severely limits the depth of inference. The post hoc search for inflammatory markers feels more like a salvage attempt to add mechanistic relevance, yet lacks granularity and biochemical specificity. | ||
+ | |||
+ | Additionally, | ||
+ | |||
+ | From a neurosurgical perspective, | ||
+ | |||
+ | **Final Verdict:** Weak in analytical depth, methodologically limited, and of minimal practical value to neurosurgeons. | ||
+ | |||
+ | **Takeaway for the Practicing Neurosurgeon: | ||
+ | |||
+ | **Bottom Line:** Bibliometric trends alone are insufficient to unravel the molecular basis of OCD, particularly in the context of COVID-19. | ||
+ | |||
+ | **Rating:** 3/10 | ||
+ | |||
+ | **Title:** Mapping research trends in obsessive-compulsive disorder before and after the COVID-19 pandemic: a bibliometric analysis focusing on its molecular mechanisms | ||
+ | **Citation: | ||
+ | **Publication Date:** July 2, 2025 | ||
+ | **Corresponding Author Email:** [Not provided in abstract; recommend direct access via journal or institutional directory] | ||
+ | |||
+ | **Categories: | ||
+ | **Tags:** obsessive-compulsive disorder, COVID-19, molecular mechanisms, bibliometric analysis, VOSviewer, inflammation, | ||
+ | |||
+ | |||
+ | ===== Obsessive-compulsive disorder case series ===== | ||
+ | |||
+ | [[Obsessive-compulsive disorder case series]]. | ||
+ | |||
+ | ===== Retrospective anatomical overlay studies ===== | ||
+ | |||
+ | In a retrospective anatomical overlay study combining clinical outcomes and structural neuroimaging. It leverages [[connectomic_analysis]] and normative [[tractography]] data to assess the therapeutic relevance of different [[deep_brain_stimulation|Deep Brain Stimulation]] (DBS) targets in [[treatment-resistant_obsessive-compulsive_disorder|treatment-resistant OCD]] (TR-OCD). The research draws from 26 patient cases across two neurosurgical centers, making it a multi-center retrospective cohort study | ||
+ | ((Coenen VA, Polosan M, Schläpfer TE, Chabardes S, Meyer-Doll DM, Czornik M, Sürücü O, Baldermann JC, Endres D, Urbach H, Reinacher PC, Rau A, Döbrössy MD, Sajonz BEA, Reisert M. Deconstructing a common pathway concept for Deep Brain Stimulation in the case of Obsessive-Compulsive Disorder. Mol Psychiatry. 2025 Apr 6. doi: 10.1038/ | ||
+ | |||
+ | ===== Summary and Critical Analysis ===== | ||
+ | The study addresses a fundamental assumption in the field of psychiatric neurosurgery: | ||
+ | |||
+ | Key Findings: | ||
+ | |||
+ | The [[ocd_response_tract|Obsessive-Compulsive Disorder Response Tract]] (ORT) is shown to be a subset of the broader slMFB. | ||
+ | |||
+ | DBS targeting the amSTN may also reach into slMFB territories, | ||
+ | |||
+ | The [[dorsomedial_prefrontal_cortex]] (dmPFC) is identified as a potential hub for sub-network convergence. | ||
+ | |||
+ | slMFB appears to encompass all relevant OCD sub-networks and may serve as a superior, unified target when stimulated near the [[ventral_tegmental_area]] (VTA). | ||
+ | |||
+ | Strengths: | ||
+ | |||
+ | The use of individualized [[volume_of_activated_tissue]] (VAT) modeling allows for a precise correlation between anatomical targeting and clinical outcome. | ||
+ | |||
+ | A robust integration of patient-specific data with normative [[connectome]] atlases. | ||
+ | |||
+ | Suggests clinically relevant refinements to current DBS targeting strategies by deconstructing the notion of a singular therapeutic pathway. | ||
+ | |||
+ | Limitations: | ||
+ | |||
+ | As a retrospective analysis, the study lacks randomization and prospective validation. | ||
+ | |||
+ | Only two DBS targets are examined; this might limit generalizability across other less commonly used targets. | ||
+ | |||
+ | Clinical outcomes are reduced to [[yale_brown_obsessive_compulsive_scale]] (Y-BOCS) scores at 24 months, without deeper exploration of functional or quality-of-life changes. | ||
+ | |||
+ | Implications: | ||
+ | |||
+ | ===== Conclusion ===== | ||
+ | Rather than reinforcing the prevailing notion of a singular optimal fiber tract for all DBS treatments in OCD, this study advocates for individualized targeting that respects the complexity of OCD's distributed sub-networks. The findings hold potential for reshaping future [[surgical_planning]], |